Financials
- Market Capitalization 7.78 M
- Employee 23
- Founded 2015
- CEO N/A
- Website www.boltbio.com
- Headquarter Delaware, United States
- FIGI BBG00N8MY5V9
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4854 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 8.63 USD | +3.48% | +2.25% | +58.35% | -9.24% | 8.20 M USD | ||
| 4869 | ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 6.03 USD | +1.01% | +8.84% | +13.56% | +286.54% | 7.81 M USD | ||
| 4873 | ELOX Eloxx Pharmaceuticals, Inc. | 11.26 USD | -0.79% | +0.90% | -25.23% | +12.60% | 7.75 M USD | ||
| 4883 | PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.69 USD | +4.55% | -4.17% | -12.66% | -36.11% | 7.41 M USD |
Frequently asked questions about Bolt Biotherapeutics, Inc. - Common Stock
What is the Bolt Biotherapeutics, Inc. - Common Stock stock price today?
The current price of Bolt Biotherapeutics, Inc. - Common Stock (BOLT) is 4.05. Over the past 24 hours, the stock has changed by +7.14%. Follow the BOLT chart for real-time price dynamics.
What is the stock ticker of Bolt Biotherapeutics, Inc. - Common Stock?
Bolt Biotherapeutics, Inc. - Common Stock trades under the ticker BOLT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Bolt Biotherapeutics, Inc. - Common Stock stock going up?
BOLT has changed by +0.25% over the last week, -12.90% over the last month, and -28.95% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Bolt Biotherapeutics, Inc. - Common Stock net income for the last quarter?
Bolt Biotherapeutics, Inc. - Common Stock reported net income of -7.24 M for the last quarter. The previous quarter showed -6.63 M, which means net income changed by -9.24%.
How many employees does Bolt Biotherapeutics, Inc. - Common Stock have?
As of the latest available data, Bolt Biotherapeutics, Inc. - Common Stock has 23 employees. Workforce size can provide additional context about the company's scale and operations.
What is Bolt Biotherapeutics, Inc. - Common Stock EBITDA?
Bolt Biotherapeutics, Inc. - Common Stock EBITDA is -7.4 M, and its EBITDA margin is -28.45 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Bolt Biotherapeutics, Inc. - Common Stock stock?
You can buy Bolt Biotherapeutics, Inc. - Common Stock (BOLT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Bolt Biotherapeutics, Inc. - Common Stock stock?
Investing in Bolt Biotherapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BOLT chart and related analysis on metatrader.com as part of your research.